News Analysis

Most Recent

Scientists react to US flu plan

By | November 23, 2005

Critics say there are many holes left to fill; U.S. government defends proposal

0 Comments

Gov't: Louisiana university to get funds

By | November 22, 2005

Shortfall that could cause faculty layoffs will be addressed, says the state

0 Comments

Financial crisis looms at LSU

By | November 18, 2005

Louisiana scientists say the interim threat from Katrina is real and could cause further setbacks, layoffs

0 Comments

Stem cell teamwork stops after split

By | November 18, 2005

American stem cell scientists reluctant to move forward with U.S.-Korea collaborations

0 Comments

Groups seek biotech funding reforms

By | November 17, 2005

Research, biotech organizations are requesting grants for venture capital-backed small businesses

0 Comments

EU plans to cut animal tests

By | November 16, 2005

Industry groups pledge to collaborate on refining, reducing, and replacing the use of lab animals

0 Comments

Acrylamide study sparks German debate

By | November 15, 2005

Scientists argue over validity of report about acrylamide sources

0 Comments

Ethiopian biotech institute planned

By | November 15, 2005

Center, slated to cost $1.8 million, has goal of fighting hunger and poverty in the region

0 Comments

Job cuts in Aussie science

By | November 9, 2005

Scientists raise concerns after Australia's top government science organization decides to trim support staff

0 Comments

Italian academics protest reforms

By | November 8, 2005

Researchers argue recently-approved changes don't do enough to reform system

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech